Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment

Fig. 2

a Time-dependent ROC curves for the CEA, CA19-9, CA72-4 as well as the post-NACT CTM according to 3-year progression-free survival (PFS). The AUCs for the four indicators is presented in the plot. While all performed statistical significance compared to reference, Compared with the AUC in the CEA, CA19-9 and CA72-4 group, the AUC in combination group was significantly increased (vs. CEA, P = 0.003; vs. CA19-9, P = 0.011; vs. CA72-4 P < 0.001). b Accuracy of recurrence prediction as a function of follow-up months. The time-dependent AUC values for three TMs and post-NACT CTM were computed for each time point separated by month. The prediction accuracy was largely stable in the combination method except during the first three after surgery

Back to article page